Valuation: Becton, Dickinson and Company

Market Cap 53.49B 48.01B 44.33B 40.2B 75.13B 5,081B 76.06B 531B 211B 2,663B 201B 197B 8,446B P/E 2026 *
39x
P/E 2027 * 23.3x
Enterprise Value 69.38B 62.27B 57.49B 52.14B 97.45B 6,590B 98.64B 689B 274B 3,454B 260B 255B 10,954B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.42x
Free-Float
73.18%
Yield 2026 *
2.13%
Yield 2027 * 2.17%
1 day-0.52%
1 week+1.03%
Current month+9.39%
1 month+6.51%
3 months+23.21%
6 months+30.34%
Current year+0.89%
1 week 191.72
Extreme 191.72
200.47
1 month 175.71
Extreme 175.71
200.47
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
259.92
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Executive/Senior Manager

-76 0.0000%
02/09/26 Tax

Chief Financial Officer

-190 0.0001%
26/08/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+1.03%+4.68%-22.18% 53.49B
-1.61%+0.83%-18.78%+11.25% 181B
-1.30%-0.79%-21.30%+15.30% 117B
-0.66%-0.26%+0.27%+35.94% 116B
+3.89%+20.80%-42.56%+8.20% 89.94B
-0.72%-4.54%-2.48%+74.64% 62.97B
+1.00%+3.09%+14.65%+83.00% 55.43B
-1.12%+1.02%-12.94%+44.01% 44.92B
-0.66%+3.26%-4.83%-8.81% 33.87B
-3.13%-7.81% - - 29.56B
Average -0.47%+2.75%-9.25%+26.82% 78.51B
Weighted average by Cap. -0.44%+3.01%-12.63%+24.54%

Financials

2026 *2027 *
Net sales 19.28B 17.3B 15.98B 14.49B 27.08B 1,831B 27.41B 192B 76.07B 960B 72.36B 70.81B 3,044B 19.73B 17.71B 16.35B 14.83B 27.71B 1,874B 28.05B 196B 77.85B 982B 74.05B 72.47B 3,115B
Net income 1.41B 1.26B 1.17B 1.06B 1.98B 134B 2B 13.97B 5.55B 70.02B 5.28B 5.17B 222B 2.19B 1.97B 1.82B 1.65B 3.08B 208B 3.12B 21.78B 8.65B 109B 8.23B 8.05B 346B
Net Debt 15.88B 14.26B 13.16B 11.94B 22.31B 1,509B 22.59B 158B 62.68B 791B 59.63B 58.35B 2,508B 13.95B 12.52B 11.56B 10.48B 19.6B 1,325B 19.84B 139B 55.05B 695B 52.37B 51.25B 2,203B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
27/10/26 $195.89 -0.25% 648,578
26/10/26 $196.39 -1.27% 1,640,118
23/10/26 $198.91 -0.75% 1,304,245
22/10/26 $200.42 +3.13% 1,383,256
21/10/26 $194.34 +0.28% 1,074,405
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
196.39USD
Average target price
195.57USD
Spread / Average Target
-0.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company